Search - tctmd.com

Displaying 21 - 40 of 141

Sort: Relevancy | Date

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Conference News ISC 2024

Radial Access for Acute Stroke Interventions Takes Longer, No Safety Gains

Todd Neale

February 12, 2024

News Daily News

Outpatient Management of Acute PE Remains Underused

Todd Neale

January 29, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2023

Caitlin E. Cox

September 04, 2023

News Conference News ESC 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

L.A. McKeown

August 30, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2023

Shelley Wood

May 31, 2023

News Conference News SCAI 2023

FLASH: PE Patients Show Ongoing Clinical, QoL Gains With Thrombectomy

L.A. McKeown

May 21, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Conference News ISET 2023

The PE Pipeline: Evidence Trickles in for Catheter-Based Therapies

Caitlin E. Cox

January 23, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Todd Neale

October 19, 2022

Presentation TCT 2022

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

Presenter: Teresa Carman

September 19, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2022

Shelley Wood

September 01, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

Advertisement

June 2024 Dispatch for the CV Team

Radial Access for Acute Stroke Interventions Takes Longer, No Safety Gains

Outpatient Management of Acute PE Remains Underused

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Top Endovascular News of 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

TCTMD’s Top 10 Most Popular Stories for August 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

What’s Going to Be Hot at ESC 2023?

TCTMD’s Top 10 Most Popular Stories for May 2023

FLASH: PE Patients Show Ongoing Clinical, QoL Gains With Thrombectomy

What’s Going to Be Hot at ACC/WCC 2023?

The PE Pipeline: Evidence Trickles in for Catheter-Based Therapies

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

FLASH: More Data to Support Mechanical Thrombectomy in PE

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

TCTMD’s Top 10 Most Popular Stories for August 2022

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content